Olivier Taelman
Chief Executive Officer bij NYXOAH SA
Vermogen: 6 M $ op 31-03-2024
Profiel
Olivier Taelman is currently the Chief Executive Officer & Executive Director at Nyxoah SA. Prior to his current position, he worked as the Business Director-Neuromodulation at Nevro Corp.
from 2013 to 2015, and as the Vice President-Europe at Autonomic Technologies, Inc. from 2015 to 2019.
Mr. Taelman completed his undergraduate degree at Hasselt University and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NYXOAH SA
1.47% | 18-03-2024 | 419 930 ( 1.47% ) | 6 M $ | 31-03-2024 |
Actieve functies van Olivier Taelman
| Bedrijven | Functie | Begin |
|---|---|---|
| NYXOAH SA | Chief Executive Officer | 01-11-2019 |
Eerdere bekende functies van Olivier Taelman
| Bedrijven | Functie | Einde |
|---|---|---|
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01-11-2019 |
| NEVRO CORP. | Corporate Officer/Principal | 01-12-2015 |
Opleiding van Olivier Taelman
| Hasselt University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NEVRO CORP. | Health Technology |
| NYXOAH SA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
